HomeTagsBayer

Tag: Bayer

Bayer and Rad AI Announce Collaboration agreement

Collaboration brings together Rad AI’s generative AI radiology reporting solutions and patient follow-up management solution with Bayer’s Calantic™ Digital Solution Platform As experts from around...

Bayer and Aignostics to collaborate on next generation precision oncology

Bayer and Aignostics GmbH announced a strategic collaboration on several artificial intelligence (AI)-powered approaches with applications in precision oncology drug research and development. Aignostics...

Bayer and Recursion focus research collaboration on Oncology

Bayer and US-based Recursion Pharmaceuticals, Inc., a clinical stage TechBio company decoding biology to industrialize drug discovery, announced that they have updated the focus...

Recent Published

Sumeet Arora

AITech365 Interview with Sumeet Arora, Chief Product Officer at Teradata

“Every agent needs its own identity, access limited to only the data and systems its task requires, and a human owner who is accountable...
AI-Assisted Security Operations Workflow

The AI Playbook for Building an AI-Assisted Security Operations Workflow

Security operations centers (SOCs) are dealing with a growing challenge. Security teams must monitor thousands of alerts, investigate suspicious activity and respond to threats...
OpenAI

OpenAI Appoints Tom R. as Global Head of Applied AI Engineering

OpenAI has appointed Tom R. as its new Global Head of Applied AI Engineering, adding to its leadership as the company continues to advance...
CloudMoyo

Terrence Davenport Joins CloudMoyo as Associate Director of Microsoft Data & AI

CloudMoyo has strengthened its Microsoft Data and AI leadership with the appointment of Terrence Davenport, MBA, as Associate Director, Solutions Architecture – Microsoft Data...
CRISPR Therapeutics

CRISPR Therapeutics Appoints Siva Sakhamuri as Chief Technical Officer

CRISPR Therapeutics has appointed Sivakesava (Siva) Sakhamuri, Ph.D., as Chief Technical Officer (CTO), strengthening its leadership as the biotechnology company advances its gene-editing and...